Overview

The First International Pharmaceutical Compliance Congress and Best Practices Forum was held in June 2007 to bring together company compliance professionals, regulators, lawyers, and consultants working in this interesting and expanding field. The purpose was to hold a truly global conference addressing the key issues impacting our industries. The first international conference agenda was developed with inputs from company compliance professionals on topics they wanted to know more about, which continues to be one of the greatest strengths of these conferences.

The 2018 Co-Chairs led the design of the Congress around relevant Global Pharma and Medical Device Compliance Codes Update, current compliance issues, and emerging trends pertaining to:

Anti-corruption and Anti-bribery Policy
Relationships with Patient Support Programs
Direct Sponsorship of Healthcare Professionals at Third Party Events
Third-Party Risk Management, Due Diligence, and Compliance Monitoring
EU General Data Protection Regulation (GDPR)
Social Responsibility and the Ethics of Artificial Intelligence
Compliance Issues in Market access and Outcomes-Based Value-Added Services, and
The next generation of ethics and compliance programs.

This year the Congress features keynote speakers from important organizations and industry associations including the International Society of Healthcare Ethics and Compliance Professionals (ETHICS), European Patients Forum (EPF), the European Commission, the European Data Protection Supervisor, the Organisation for Economic Co-operation and Development (OECD), the UK Serious Fraud Office (SFO), the US Department of Justice FCPA Unit and the US Securities & Exchange Commission (SEC), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the UK Prescription Medicines Code of Practice Authority, the Code of Practice Surveillance Unit, Farmaindustria (Spain), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and MedTech Europe.

Listen to and engage in dialogue with our keynote speakers, industry experts working within pharmaceutical and medical devices companies, as well as, legal counsel and industry partners as we navigate the current landscape, share best practices, and discuss practical guidance for the future of our profession.

Over the years, the International Congresses have been held in Berlin (2010), Brussels (2007, 2015), Budapest (2012), Dubai (2014), Istanbul (2011), Madrid (2013), Paris (2008), Rome (2009), Warsaw (2016) and Lisbon (2017). In 2018, we are pleased to hold the Twelfth International Pharmaceutical Compliance Congress and Best Practices Forum in Vienna, Austria. Our attendees will be welcomed by Jan Oliver Huber, DR JUR, General Secretary, Association of the Austrian Pharmaceutical Industry (PHARMIG).

WHO SHOULD ATTEND

Pharmaceutical Manufacturers
Medical Device Manufacturers
Generic Pharmaceutical Manufacturers
Site Management Organizations
Clinical Research Organizations
Management Companies
Wholesale, Retail, Mail Order and Internet Pharmacies
Health Care Regulators and Policy Makers
Pharmaceutical and Health Care Executives and Board Members
Regulatory and Compliance Professionals
Medical Directors
Physicians and Other Health Care Professionals
Pharmacists

Food and Drug Law Attorneys
Health Care Attorneys and In-house Counsel
Compliance Officers
Privacy Officers
Ethics Officers and Corporate Social Responsibility Personnel
Pharmaceutical Consultants
Investment Bankers
Venture Capitalists
Health Services Researchers and Academics
Auditors
Promotion Signatories/Approvers
Risk Management Personnel
Governmental Policy Makers and Regulators

SPONSOR:

INTERNATIONAL SOCIETY OF HEALTHCARE ETHICS AND COMPLIANCE PROFESSIONALS (ETHICS) was incorporated as an Association governed by French law in January 2012, currently comprised of around 50 members all active in major pharma and medical device companies. ETHICS aims to be recognised as an independent international association of professionals, which sets standards of Ethics and Compliance and shapes and influences strategies in the changing Healthcare environment for the ultimate benefit of Patients and Society at large.